These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22196956)

  • 1. Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia.
    Francis S; Bareford D; Baggott C; Thachil J
    Leuk Res; 2012 Apr; 36(4):488-90. PubMed ID: 22196956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.
    Prescrire Int; 2006 Jun; 15(83):83-6. PubMed ID: 16764090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the European LeukaemiaNet criteria for clinicohaematological response and resistance/intolerance to hydroxycarbamide in essential thrombocythaemia.
    Hernández-Boluda JC; Alvarez-Larrán A; Gómez M; Angona A; Amat P; Bellosillo B; Martínez-Avilés L; Navarro B; Teruel A; Martínez-Ruiz F; Besses C
    Br J Haematol; 2011 Jan; 152(1):81-8. PubMed ID: 21083657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
    Vélez A; García-Aranda JM; Moreno JC
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):243-4. PubMed ID: 10461646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
    Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperalgesic malleolar ulcer: recovery on the withdrawal of hydroxyurea].
    Liebschutz S; Quéré I; Lukasik E; Dereure O; Rondes J; Janbon C
    Rev Med Interne; 1998 May; 19(5):360-1. PubMed ID: 9775174
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia.
    Weston H; Cowell V; Grimmett K; Saal R; Jones M; Mills T; Gill D; Marlton P; Bird R; Mollee P
    Intern Med J; 2011 May; 41(5):408-15. PubMed ID: 20681956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice.
    Reilly JT
    Eur J Haematol Suppl; 2007 Oct; (68):32-4. PubMed ID: 17727564
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study.
    Gugliotta L; Besses C; Griesshammer M; Harrison C; Kiladjian JJ; Coll R; Smith J; Abhyankar B; Birgegård G
    Haematologica; 2014 Apr; 99(4):679-87. PubMed ID: 24334294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ulcers on the legs and feet: a seldom recognised side effect of hydroxyurea].
    Janssen JJ; Ossenkoppele GJ
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1517-20. PubMed ID: 12924084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leg ulcers in patient affected by polycythemia vera in treatment with hydroxycarbamide. Case report].
    Chiummariello S; Arleo S; Alfano C
    G Chir; 2010 Mar; 31(3):120-3. PubMed ID: 20426925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase.
    Fioramonti P; Fino P; Parisi P; Scuderi N; Onesti MG
    In Vivo; 2012; 26(6):1053-6. PubMed ID: 23160693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leg ulcer in a patient associated with hydroxyurea therapy.
    Dissemond J; Hoeft D; Knab J; Franckson T; Kroger K; Goos M
    Int J Dermatol; 2006 Feb; 45(2):158-60. PubMed ID: 16445510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anagrelide in primary thrombocythemia].
    Knutsen H; Hysing J
    Tidsskr Nor Laegeforen; 2001 May; 121(12):1478-82. PubMed ID: 11449771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leg ulcers in elderly on hydroxyurea: a single center experience in Ph- myeloproliferative disorders and review of literature.
    Ruzzon E; Randi ML; Tezza F; Luzzatto G; Scandellari R; Fabris F
    Aging Clin Exp Res; 2006 Jun; 18(3):187-90. PubMed ID: 16804363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of essential thrombocythemia].
    Kuramoto A
    Rinsho Ketsueki; 1995 May; 36(5):480-6. PubMed ID: 7783354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical approach to treating essential thrombocythaemia: case studies.
    Reilly JT
    Eur J Haematol Suppl; 2007 Oct; (68):40-2. PubMed ID: 17727566
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
    Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N
    Am J Hematol; 2009 Apr; 84(4):215-20. PubMed ID: 19208420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.